Clinical Insights: July 6, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) Injection – New Drug Approval – June 30, 2021 – Jazz Pharmaceuticals plc announced the U.S. Food and Drug Administration (FDA) approval of…
Clinical Insights: June 29, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Verkazia™ (cyclosporine) Ophthalmic Emulsion – New Drug Approval – June 23, 2021 – Santen Pharmaceutical Co., Ltd announced that the U.S. Food and Drug Administration (FDA) has approved…
Connect with Our Experts at the 340B Coalition Summer Conference
Attending the 340B Coalition Summer Conference July 20-22 and 27-28? Connect with us! Our 340B experts are ready to meet with you, arrange a dashboard analytics demo and discuss our 340B compliance solutions. Meeting with RxStrategies is easy: –Connect with us throughout the event and visit our virtual booth. –Attend our Vendor Demo on 7/22 from 1:00…
Clinical Insights: June 22, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Rezipres® (ephedrine hydrochloride) Injection – New Drug Approval – June 15, 2021 – Eton Pharmaceuticals, Inc announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres®…
Clinical Insights: June 15, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Prevnar 20™ (pneumococcal 20-valent conjugate vaccine) Injection – New Vaccine Approval – June 8, 2021 – Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has…
RxStrategies to Attend the Summer HCP 2021 Live Online Reverse Expo
Our team is looking forward to connecting with health care leaders during the Summer HCP 2021 Live Online Reverse Expo, June 22-24. Make sure to stop by the RxStrategies virtual booth during the Virtual Suppliers Showcase to meet with our 340B experts. Contact Krista Scanlon at kscanlon@rxstrateiges.com to schedule a demo or one-on-one appointment…
Clinical Insights: June 8, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Tembexa™ (brincidofovir) – New Drug Approval – June 4, 2021 – The U.S. Food and Drug Administration approved Tembexa™ (brincidofovir) to treat smallpox. Although the World Health Organization declared…
Clinical Insights: June 1, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Lumakras™ (sotorasib) – New Drug Approval – May 28, 2021 – The U.S. Food and Drug Administration approved Lumakras™ (sotorasib) as the first treatment for adult patients with…
Clinical Insights: May 25, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Rybrevant™ (amivantamab-vmjw) Injection – New Drug Approval – May 21, 2021 – The U.S. Food and Drug Administration approved Rybrevant™ (amivantamab-vmjw) as the first treatment for adult patients with…
Clinical Insights: May 18, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Empaveli™ (pegcetacoplan) Injection – New Drug Approval – May 14, 2021 – Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in targeted C3 therapies, announced that the U.S….
Clinical Insights: May 11, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New/Updated Drug Shortage May 07, 2021 Azacitidine for Injection (Currently in Shortage) Bumetanide…
Clinical Insights: May 4, 2021
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Kloxxado™ (naloxone hydrochloride) Nasal Spray – New Drug Approval – April 30, 2021 – The U.S. Food and Drug Administration announced the approval of a higher dose naloxone hydrochloride…